Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
3 trials
Recent
Start date
Enrollment
Completed
×
Ovarian Neoplasms
×
dostarlimab
×
Clear all
Filters
3
NCT03574779
2025-07-15
OPAL
Tesaro, Inc.
Phase 2
Completed
77 enrolled
8 charts
NCT03250832
2024-04-11
CITRINO
Tesaro, Inc.
Phase 1
Completed
111 enrolled
48 charts
NCT05751629
2023-04-21
COHORT-A
Tesaro, Inc.
Phase 2
Completed
41 enrolled
17 charts